BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 10751859)

  • 1. Percent free prostate specific antigen and cancer detection in black and white men with total prostate specific antigen 2.5 to 9.9 ng./ml.
    Fowler JE; Sanders J; Bigler SA; Rigdon J; Kilambi NK; Land SA
    J Urol; 2000 May; 163(5):1467-70. PubMed ID: 10751859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of cancer detection in black and white men with normal digital rectal examination but prostate specific antigen equal or greater than 4.0 ng/mL.
    Fowler JE; Bigler SA; Farabaugh PB
    Cancer; 2002 Mar; 94(6):1661-7. PubMed ID: 11920526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of the serum prostate specific antigen concentrations and Gleason histologic scores of black and white men with prostate carcinoma.
    Fowler JE; Bigler SA
    Cancer; 1999 Sep; 86(5):836-41. PubMed ID: 10463983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of lower prostate specific antigen cutoffs for prostate cancer screening in black and white men.
    Smith DS; Carvalhal GF; Mager DE; Bullock AD; Catalona WJ
    J Urol; 1998 Nov; 160(5):1734-8. PubMed ID: 9783942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer detection in Black and White men with abnormal digital rectal examination and prostate specific antigen less then 4 ng./ml.
    Fowler JE JR; Bigler SA; Farabaugh PB; Wilson SS
    J Urol; 2000 Dec; 164(6):1961-3. PubMed ID: 11061891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between prostate-specific antigen and prostate volume in black and white men with benign prostate biopsies.
    Fowler JE; Bigler SA; Kilambi NK; Land SA
    Urology; 1999 Jun; 53(6):1175-8. PubMed ID: 10367848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of carcinoma of the prostate: ethnic variations.
    Presti JC; Hovey R; Bhargava V; Carroll PR; Shinohara K
    J Urol; 1997 Mar; 157(3):907-11; discussion 911-2. PubMed ID: 9072597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial differences in operating characteristics of prostate cancer screening tests.
    Smith DS; Bullock AD; Catalona WJ
    J Urol; 1997 Nov; 158(5):1861-5; discussion 1865-6. PubMed ID: 9334618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer.
    Henderson RJ; Eastham JA; Culkin DJ; Kattan MW; Whatley T; Mata J; Venable D; Sartor O
    J Natl Cancer Inst; 1997 Jan; 89(2):134-8. PubMed ID: 8998182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.
    Moul JW; Sesterhenn IA; Connelly RR; Douglas T; Srivastava S; Mostofi FK; McLeod DG
    JAMA; 1995 Oct; 274(16):1277-81. PubMed ID: 7563532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
    Djavan B; Zlotta AR; Byttebier G; Shariat S; Omar M; Schulman CC; Marberger M
    J Urol; 1998 Aug; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study of correlations between biopsy-detected high grade prostatic intraepithelial neoplasia, serum prostate specific antigen concentration, and race.
    Fowler JE; Bigler SA; Lynch C; Wilson SS; Farabaugh PB
    Cancer; 2001 Apr; 91(7):1291-6. PubMed ID: 11283929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination.
    Uzzo RG; Pinover WH; Horwitz EM; Parlanti A; Mazzoni S; Raysor S; Mirchandani I; Greenberg RE; Pollack A; Hanks GE; Watkins-Bruner D
    Urology; 2003 Apr; 61(4):754-9. PubMed ID: 12670560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-specific reference ranges for serum prostate-specific antigen in black men.
    Morgan TO; Jacobsen SJ; McCarthy WF; Jacobson DJ; McLeod DG; Moul JW
    N Engl J Med; 1996 Aug; 335(5):304-10. PubMed ID: 8663870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests.
    Mäkinen T; Tammela TL; Hakama M; Stenman UH; Rannikko S; Aro J; Juusela H; Määttänen L; Auvinen A
    J Urol; 2001 Oct; 166(4):1339-42. PubMed ID: 11547069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.
    Djavan B; Zlotta A; Remzi M; Ghawidel K; Basharkhah A; Schulman CC; Marberger M
    J Urol; 2000 Apr; 163(4):1144-8; discussion 1148-9. PubMed ID: 10737484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percentage of free PSA in black versus white men for detection and staging of prostate cancer: a prospective multicenter clinical trial.
    Catalona WJ; Partin AW; Slawin KM; Naughton CK; Brawer MK; Flanigan RC; Richie JP; Patel A; Walsh PC; Scardino PT; Lange PH; deKernion JB; Southwick PC; Loveland KG; Parson RE; Gasior GH
    Urology; 2000 Mar; 55(3):372-6. PubMed ID: 10699613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percent free prostate specific antigen in the total prostate specific antigen 2 to 4 ng./ml. range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng./ml. range.
    Haese A; Dworschack RT; Partin AW
    J Urol; 2002 Aug; 168(2):504-8. PubMed ID: 12131298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of percent free prostate specific antigen and prostate specific antigen density as methods to enhance prostate specific antigen specificity in early prostate cancer detection in men with normal rectal examination and prostate specific antigen between 4.1 and 10 ng./ml.
    Morote J; Raventós CX; Lorente JA; Lopez-Pacios MA; Encabo G; de Torres I; Andreu J
    J Urol; 1997 Aug; 158(2):502-4. PubMed ID: 9224333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the predictive accuracy of serum prostate specific antigen levels and prostate specific antigen density in the detection of prostate cancer in Hispanic-American and white men.
    Lam JS; Cheung YK; Benson MC; Goluboff ET
    J Urol; 2003 Aug; 170(2 Pt 1):451-6. PubMed ID: 12853797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.